DSK Bank EAD :企業の戦略・SWOT・財務情報

◆英語タイトル:DSK Bank EAD - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C9730
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブルガリア
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

DSK Bank EAD – Strategy, SWOT and Corporate Finance Report
Summary

DSK Bank EAD – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

DSK Bank EAD (DSK Bank), a subsidiary of OTP Bank Plc., is a provider of personal and business banking, investment, insurance, and related financial solutions. It offers a range of accounts and deposits; debit, credit, virtual, and prepaid cards; consumer and business loans and mortgages; private banking; financial guarantees, and e-banking solutions. The bank provides investment advisory, asset management, mutual funds, brokerage, currency trading, currency and interest rate risk management; and other investment solutions. It also provides insurance, custodial services, remittance, foreign exchange, safe deposit facilities, factoring, trade finance, cash management, and merchant services. DSK Bank is headquartered in Sofia, Bulgaria.

Scope

- Detailed information on DSK Bank EAD required for business and competitor intelligence needs
- A study of the major internal and external factors affecting DSK Bank EAD in the form of a SWOT analysis
- An in-depth view of the business model of DSK Bank EAD including a breakdown and examination of key business segments
- Intelligence on DSK Bank EAD ‘s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about DSK Bank EAD , such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of DSK Bank EAD and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess DSK Bank EAD as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on DSK Bank EAD ‘s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
DSK Bank EAD : Company Overview 7
DSK Bank EAD : Overview and Key Facts 7
DSK Bank EAD : Overview 7
DSK Bank EAD : Key Facts 7
DSK Bank EAD : Key Employees 8
DSK Bank EAD : Key Employee Biographies 11
DSK Bank EAD : Major Products and Services 13
DSK Bank EAD : Company History 14
DSK Bank EAD : Management Statement 17
DSK Bank EAD : Locations and Subsidiaries 18
DSK Bank EAD : Key Competitors 20
DSK Bank EAD : Company Analysis 21
DSK Bank EAD : Business Description 21
DSK Bank EAD : SWOT Analysis 22
DSK Bank EAD : SWOT Overview 22
DSK Bank EAD : Strengths 22
DSK Bank EAD : Weaknesses 23
DSK Bank EAD : Opportunities 23
DSK Bank EAD : Threats 23
DSK Bank EAD : Corporate Financial Deals Activity 25
DSK Bank EAD : Financial Deals Overview 25
DSK Bank EAD : Targets and Partners 27
DSK Bank EAD : Top Deals 2014 – 2018YTD* 28
DSK Bank EAD : Mergers and Acquisitions 29
Appendix 30
Contact Us 30
Methodology 30
About MarketLine 31

List of Tables
Table 1: DSK Bank EAD : Key Facts
Table 2: DSK Bank EAD : Key Employees
Table 3: DSK Bank EAD : Company History
Table 4: DSK Bank EAD : Locations and Subsidiaries
Table 5: DSK Bank EAD : Key Competitors
Table 6: DSK Bank EAD : Deal Activity by Deal Type - Volume (TTM*)
Table 7: DSK Bank EAD : M&A Activity by Geography (TTM*)
Table 8: DSK Bank EAD : Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: DSK Bank EAD : Targets and Partners
Table 10: DSK Bank EAD : Top Deals 2014 - 2018YTD*
Table 11: DSK Bank EAD : M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: DSK Bank EAD : M&A Activity by Geography (2014 - YTD*2018)

List of Figures
Figure 1: DSK Bank EAD : Deal Activity by Deal Type - Volume (TTM*)
Figure 2: DSK Bank EAD : M&A Activity by Geography (TTM*)
Figure 3: DSK Bank EAD : Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: DSK Bank EAD : M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: DSK Bank EAD : M&A Activity by Geography (2014 - YTD*2018)

★海外企業調査レポート[DSK Bank EAD :企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Avis Budget Group, Inc.:戦略・SWOT・企業財務分析
    Avis Budget Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Avis Budget Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Wegmans Food Markets Inc:企業の戦略的SWOT分析
    Wegmans Food Markets Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Mallinckrodt LLC:医療機器:M&Aディール及び事業提携情報
    Summary Mallinckrodt LLC (Mallinckrodt), formerly Therakos Inc, a subsidiary of Mallinckrodt Plc, is a provider of autologous immune cell therapy through extracorporeal photopheresis. The company provides Therakos Cellex Photopheresis system, which is indicated for use in ultraviolet-A irradiation i …
  • CohBar Inc (CWBR):製薬・医療:M&Aディール及び事業提携情報
    Summary CohBar Inc (CohBar) is a developer of mitochondria based therapeutics. The company develops a class of drugs to treat a wide range of diseases associated with aging and metabolic dysfunction such as non-alcoholic steatohepatitis, obesity, type 2 diabetes, cancer, cardiovascular disease and C …
  • Brooks MacDonald Group PLC (BRK):企業の財務・戦略的SWOT分析
    Brooks MacDonald Group PLC (BRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Zensar Technologies Limited (ZENSARTECH):企業の財務・戦略的SWOT分析
    Zensar Technologies Limited (ZENSARTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Terumo Corporation:企業のM&A・事業提携・投資動向
    Terumo Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Terumo Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Barloworld Limited (BAW):企業の財務・戦略的SWOT分析
    Barloworld Limited (BAW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Assertio Therapeutics Inc (DEPO):製薬・医療:M&Aディール及び事業提携情報
    Summary Assertio Therapeutics Inc (Assertio), formerly Depomed Inc, is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain and other diseases of the central nervous system. Its product portfolio comprises drugs for the treatment of postherpetic neuralg …
  • Sidney Kimmel Comprehensive Cancer Center-製薬・医療分野:企業M&A・提携分析
    Summary Sidney Kimmel Comprehensive Cancer Center (Sidney Kimmel) is a healthcare service provider that concentrates on diagnosis, treatment, and prevention of cancer. The center’s specialties include cancer diagnostic and treatment planning, blood and bone marrow cancers, cancer immunotherapy, brai …
  • NxStage Medical Inc:企業の戦略的SWOT分析
    NxStage Medical Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Endologix Inc (ELGX):企業の財務・戦略的SWOT分析
    Endologix Inc (ELGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sarawak Energy Berhad:企業の戦略的SWOT分析
    Sarawak Energy Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Menarini Asia-Pacific Holdings Pte Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary A. Menarini Asia-Pacific Holdings Pte Ltd (A. Menarini Asia-Pacific), formerly Invida Group Pte Ltd, a subsidiary of A. Menarini Industrie Farmaceutiche Riunite Srl is a biopharmaceutical company that develops consumer health care products. The company operates through its divisions includin …
  • InnoPharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary InnoPharma Inc (InnoPharma), a subsidiary of Pfizer Inc is a healthcare products provider that develops generic and pharmaceutical products. The company develops formulations, which include solutions, suspensions, lyophilized, emulsions, liposomes, lipid complexes, polypeptides and carbohydr …
  • China Billion Resources Limited:企業の戦略・SWOT・財務情報
    China Billion Resources Limited - Strategy, SWOT and Corporate Finance Report Summary China Billion Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Benihana Inc.:企業の戦略・SWOT・財務分析
    Benihana Inc. - Strategy, SWOT and Corporate Finance Report Summary Benihana Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Granules India Ltd (GRANULES):製薬・医療:M&Aディール及び事業提携情報
    Summary Granules India Ltd (Granules) is a pharmaceutical manufacturing company, which carries out the research, development and manufacture of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs). The company manufactures Paracetomol, …
  • Magnolia Petroleum Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Magnolia Petroleum Plc (Magnolia Petroleum) is an oil and gas company. The company explores, acquires, and develops oil and natural gas properties. It holds interests in producing properties in two project areas such as Bakken shale in North Dakota and the proven Mississippi Lime, Woodford a …
  • Florida Keys Electric Cooperative Association, Inc.:企業の戦略的SWOT分析
    Florida Keys Electric Cooperative Association, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compe …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆